Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Different BNT162b2 and ChAdOx1-S COVID-19 Vaccination Intervals and Combinations on Reactogenicity and Humoral Immunogenicity in Adults

NCT05076227 is registered in ClinicalTrials.gov with Serge Thal as lead sponsor.

NCT NCT05076227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Different BNT162b2 and ChAdOx1-S COVID-19 Vaccination Intervals and Combinations on Reactogenicity and Humoral Immunogenicity in Adults
Lead sponsor
Serge Thal
Phase
Observational
Overall status
Completed
Start date
January 30, 2021
Completion date
March 27, 2022
Enrollment
1,206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody hypersensitivity, immunisation reaction, sars-cov2 infection, tolerance